Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant

por Law, Ernest H, Cameron, Chris
Publicado 2023

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran

por Leung, Timothy S, Law, Ernest H
Publicado 2015

Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis

por Jiang, Ruixuan, Law, Ernest, Zhou, Zhou, Yang, Hongbo, Wu, Eric Q., Seifeldin, Raafat
Publicado 2018

Voice Analysis of Cancer Experiences Among Patients With Breast Cancer: VOICE-BC

por Law, Ernest H, Auil, Maria J, Spears, Patricia A, Berg, Kiersten, Winnette, Randall
Publicado 2021

Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion

por Law, Ernest, Harrington, Rachel, Alexander, G Caleb, Saha, Soumi, Oehrlein, Elisabeth, Perfetto, Eleanor M
Publicado 2018

Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment

por Beusterien, Kathleen, Maculaitis, Martine C, Hallissey, Bernadette, Gaschler, Michael M, Smith, Mary Lou, Law, Ernest H
Publicado 2021

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

por Salvo, Elizabeth M., Ramirez, Abril Oliva, Cueto, Jenilee, Law, Ernest H., Situ, Aaron, Cameron, Chris, Samjoo, Imtiaz A.
Publicado 2021

Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

por Zhou, Zhou, Chaudhari, Paresh, Yang, Hongbo, Fang, Anna P., Zhao, Jing, Law, Ernest H., Wu, Eric Q., Jiang, Ruixuan, Seifeldin, Raafat
Publicado 2017

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

por Thaçi, Diamant, Tziotzios, Christos, Ito, Taisuke, Ko, Justin, Karadağ, Ayşe Serap, Fang, Hong, Edwards, Roger A., Bonfanti, Gianluca, Wolk, Robert, Tran, Helen, Law, Ernest
Publicado 2023

Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race

por Zhou, Jifang, Cueto, Jenilee, Ko, Naomi Y., Hoskins, Kent F., Nabulsi, Nadia A., Asfaw, Alemseged A., Hubbard, Colin C., Mitra, Debanjali, Calip, Gregory S., Law, Ernest H.
Publicado 2021

Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer

por Calip, Gregory S., Nabulsi, Nadia A., Hubbard, Colin, Asfaw, Alemseged A., Lee, Inyoung, Zhou, Jifang, Cueto, Jenilee, Mitra, Debanjali, Ko, Naomi Y., Hoskins, Kent F., Law, Ernest H.
Publicado 2022

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey

por Nabulsi, Nadia A, Naing, Khatija W, Deng, Huiwen, Cueto, Jenilee, Asfaw, Alemseged A, Hubbard, Colin C, Zhou, Jifang, Lee, Inyoung, Mitra, Debanjali, Calip, Gregory S, Law, Ernest H
Publicado 2022